Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−290KRW
−9.70 BKRW
9.59 BKRW
26.17 M
About INTRON BIO
Sector
Headquarters
Seongnam-si
Employees (FY)
77
Website
Founded
1999
ISIN
KR7048530000
FIGI
BBG001BGCLW4
iNtRON Biotechnology, Inc. engages in the development of super-bacteria treatment, antibiotics alternatives, bio new drug, molecular diagnostics and artificial blood. Its products include anti-bacterial agents, identification kits, research reagents and kits. The company was founded on January 18, 1999 and is headquartered in Seongnam-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 048530 is 6920 KRW — it has increased by 0.29% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange INTRON BIO stocks are traded under the ticker 048530.
INTRON BIO is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
048530 stock is 2.04% volatile and has beta coefficient of 0.15. Check out the list of the most volatile stocks — is INTRON BIO there?
048530 earnings for the last quarter are 60.72 KRW per share, whereas the estimation was 92.62 KRW resulting in a −34.44% surprise. The estimated earnings for the next quarter are 0.55 KRW per share. See more details about INTRON BIO earnings.
INTRON BIO revenue for the last quarter amounts to 7.01 B KRW despite the estimated figure of 7.01 B KRW. In the next quarter revenue is expected to reach 2.89 B KRW.
Yes, you can track INTRON BIO financials in yearly and quarterly reports right on TradingView.
048530 stock has fallen by 0.72% compared to the previous week, the month change is a 11.40% fall, over the last year INTRON BIO has showed a 11.62% decrease.
048530 net income for the last quarter is −3.70 B KRW, while the quarter before that showed −2.59 B KRW of net income which accounts for −42.86% change. Track more INTRON BIO financial stats to get the full picture.
Today INTRON BIO has the market capitalization of 232.67 B, it has increased by 0.44% over the last week.
Yes, 048530 dividends are paid annually. The last dividend per share was 100.00 KRW. As of today, Dividend Yield (TTM)% is 1.43%. Tracking INTRON BIO dividends might help you take more informed decisions.
Like other stocks, 048530 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTRON BIO stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 77.00 employees. See our rating of the largest employees — is INTRON BIO on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTRON BIO technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTRON BIO stock shows the sell signal. See more of INTRON BIO technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTRON BIO EBITDA is −1.42 B KRW, and current EBITDA margin is −14.33%. See more stats in INTRON BIO financial statements.